Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
UK Early Access Granted For Argenx’s Generalized Myasthenia Gravis Treatment
Efgartigimod Is Being Investigated For Several High-Need Autoimmune Conditions
May 31 2022
•
By
Vibha Sharma
Generalized MG causes weakness in many muscle groups throughout the body • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Rare Diseases
More from Pink Sheet